Move Towards ‘Default Disclosure’ In Revamped EU Transparency Guidance Concerns Industry
New guidance on data transparency from European medicines regulators will mean more administrative burden for small and medium sized companies.
New guidance on data transparency from European medicines regulators will mean more administrative burden for small and medium sized companies.